EK

Eric Kohlmann

Managing Partner at KGS Ventures

United Kingdom

Overview 

Eric Kohlmann is the Managing Partner at KGS Ventures, a global venture capital firm with a focus on deep tech, where he has successfully founded an AI/ML hedge fund and a non-profit organization. His career highlights include leading strategic business advice, startup development, and growth capital initiatives, particularly in the fields of artificial intelligence and biotechnology. Eric's current role involves overseeing investments in deep tech sectors such as AI, biotech, and fintech at various stages like Series A and Seed, positioning him as a key player in the global VC landscape with a strong emphasis on AI infrastructure and GPU cloud technology.

Work Experience 

  • Managing Partner

    2023 - Current

    KGS is a deep tech venture capital firm partnering with entrepreneurs who are looking to leverage cutting-edge, IP-centered technology to solve some of humanity's greatest challenges, including applications in neuro-tech, bioengineering, advanced materials, clean energy, and photonics. The firm is deeply embedded in global networks of next-generation entrepreneurs, VCs, industry experts, and world-leading academic institutions. With over 30 years of combined venture capital and entrepreneurship experience across multiple continents, its founders understand both sides of investing and building, creating a uniquely global and founder-support-centric firm.

  • Venture Partner

    2024

    HOF Capital is a multi-stage venture capital firm. Backed by over 200 influential, industry leaders, we look for relentlessly ambitious founders and help them build generational companies. HOF supports entrepreneurs by providing them with long-term-focused capital from idea to IPO, and helping them structure meaningful partnerships with enterprises in its LP network.

HOF Capital is a global multistage VC firm with $1 billion in AUM that partners with ambitious entrepreneurs from idea to IPO.

  • Strategic Advisor

    2024

    - GMI helps AI companies access GPUs at 2x the speed. - Leading GPU cloud provider serving top AI customers in the US and Asia. H100s available across 3 global locations. - Backed by Headline and HOF Capital

GMI Cloud provides GPU cloud access for generative AI applications.

Raised $82,000,000.00 from Wistron Corporation, Banpu NEXT and Headline Asia (formerly Infinity Ventures).

  • Board Member, Investor

    2022

  • Investor

    2022

Canaery is builds a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds.

Raised $4,000,000.00 from Florida Opportunity Fund, DeepWork Capital, Arkitekt Ventures, KdT Ventures, Breakout Ventures, IndieBio, Dolby Family Ventures, SOSV, Asymmetry Ventures and SOSV.

  • Investor

    2020

    Omneky is a leading generative AI company.

Omneky generates personalized ads at scale.

Raised $13,000,000.00 from Orbit Venture Partners, Lennox Capital Partners, DG Daiwa Ventures, Cadron Capital Partners, John Donovan, Nomura, Charlie Feng, FAST — by GETTYLAB, Darius Contractor and Gene Farrell.

  • Investor

    2018

    ◦ Investor and engaged in regular, strategic discussions with the founders. CTRL-labs announced its sale to Facebook for ~$1B in September 2019.

  • Investor

    2016

SQream makes it possible to ask bigger questions of extremely large, complicated data sets.

Raised $122,005,000.00 from Blumberg Capital, World Trade Ventures, George Kaiser Family Foundation, Schusterman Family Investments, Freddy & Helen Holdings. and ICON Continuity Fund.

  • Co-Founder, Board Member

    2013

    ◦ Invested in numerous technology startups including CTRL-labs, Sqream DB, Teralytics, Bloom Diagnostics, Omneky, Sania Therapeutics and Canaery among others. ◦ Co-investor with many leading international VC firms such as Google Ventures, Amazon Alexa Fund, Spark Capital, LUX Capital, Matrix Partners, Breyer Capital, Atomico, Horizons Ventures (Li Ka-shing) and Lakestar.

  • Co-Founder, Advisor

    2013

    ◦ Smart diagnostics startup currently in FDA approval process. ◦ Raised > $30MM of outside capital to date.

Articles About Eric

Relevant Websites